Developer docs
API playgroundTry for free, no card

Search company profiles

GeodAIsics

Full company profile

uuid000dfw7

Namestring
GeodAIsics
Legal namestring
Geodaisics
Websiteurl
geodaisics.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

GeodAIsics SAS is a French DeepTech company founded in 2021 and headquartered in La Tronche (Grenoble), France, that develops clinical and biological decision-support software powered by its proprietary Generative Manifold Learning (GML) AI technology. GML is a generative AI methodology based on variety analysis that operates on low volumes of unlabeled routine-care data, builds personalized digital twins per patient, and detects anomalies (including disease subtypes) at population and individual level. The product portfolio comprises five proprietary software lines — BrainGML (brain MRI, including DementIA / BrainGML-AD for early Alzheimer's detection and differential dementia diagnosis), OncoGML (cancer prognosis and treatment outcome prediction, with focus on elderly breast cancer patients), BioGML (blood-sample validation with personalized reference values for kidney and liver disease), OtoGML (inner-ear MRI analysis including Ménière's disease), and LAbyrInth (automatic inner-ear anomaly detection) — all built on the same algorithmic foundation.

The company operates a dual go-to-market: (1) proprietary software licensed to hospitals, radiology centers, and biology laboratories, with BrainGML/DementIA on the path to CE marking as a medical device; and (2) custom AI software development using GML for medical-device manufacturers, LIS/HIS middleware vendors, pharmaceutical companies, CROs, and veterinary clinics, exemplified by the embedded AI module within BYG4lab's Ynfectio software. A secondary revenue stream is paid professional training workshops (historically €300 per session, €50 for interns) that double as a relationship-building channel with radiologists, neurologists and ORL specialists. Distribution is primarily direct-sales driven in France with extensions into validation partnerships across French university hospitals (AP-HP, HCL, CHU Grenoble, CHU Brest, CHU Rouen, CHU Nice, Centre Léon Bérard) and one international academic link (University of Sydney), supplemented by congress presence (JFR 2022, SFNR 2023), Bayer-co-branded webinars, and strategic partnerships with HORIBA (sepsis detection, 2025) and Les Biologistes Indépendants (capital entry 2025).

GeodAIsics is privately held, has approximately 14 team members, and has raised €400,000 from 10 physician business angels in February 2023 as the only disclosed equity financing to date. The founding team combines three medical doctors (neuroradiology, oncogenetics, medical biology) with a PhD in AI as CSO, and the company holds two pending patents covering its core GML methodologies.

Short descriptiontext

GeodAIsics is a France-based DeepTech company that develops proprietary AI-powered clinical and biological decision-support software (BrainGML, OncoGML, BioGML, OtoGML, LAbyrInth) for hospitals, radiology centers, medical biology laboratories, medical-device manufacturers and CROs using its patented Generative Manifold Learning technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGrenoble, France
HQ citystring
Grenoble
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, medical imaging AI, generative manifold learning, digital twin healthcare, radiology software
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Clinical Decision Support Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Proprietary Software Licenses
TypeSubscription Recurring
Description

GeodAIsics develops and licenses proprietary clinical decision support software products (BrainGML, OncoGML, BioGML, OtoGML) to healthcare institutions, hospitals, and medical professionals. These are sold as software licenses, likely on a subscription or one-time license basis, targeting CE marking for regulatory approval.

geodaisics.com
2Custom Software Development
TypeOne Time License
Description

GeodAIsics develops custom software solutions for specific client applications using the same patented GML technology. Target clients include biological testing system manufacturers, quality control manufacturers, middleware providers, LIS/HIS vendors, pharmaceutical companies, CROs, hospitals, veterinary clinics, and medical device manufacturers.

geodaisics.com
3Professional Training and Workshops
TypeProfessional Services
Description

GeodAIsics offers paid professional training workshops for healthcare professionals (radiologists, neurologists, geriatricians) on AI applications in medical imaging. Training is offered at €300 per session (past workshops) and €50 for interns (upcoming), conducted in-person and remotely.

geodaisics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Professional Training - Past Sessions
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Past training workshops on neuro-degenerative diseases, cochleo-vestibular disorders, and demyelinating diseases were priced at €300 per session. Both in-person and remote attendance options were available.

geodaisics.com
2Upcoming Training (September 2025)
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

Upcoming training on biological Alzheimer diagnosis with MRI+AI is priced at €50 for medical interns (upon presentation of ID). Standard pricing appears to be the same session at a higher rate for other attendees.

geodaisics.com
3BrainGML-AD Software License
ModelSubscriptionBilling cadenceAnnual
Notes

Software pricing is not publicly disclosed. A gated user manual is available only for customers through the contact/request form. Prospective customers must request access via the website.

geodaisics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1BrainGML
Description

MRI analysis software for detecting anatomical changes in the brain, particularly for neurodegenerative and psychiatric disorders such as Alzheimer's, Parkinson's, and FTD.

geodaisics.com
+6 more records
Core offering1 text field

GeodAIsics develops and licenses proprietary clinical decision support software for medical imaging and biological analysis, powered by its patented Generative Manifold Learning (GML) AI technology. Core products include BrainGML (brain MRI analysis for Alzheimer's, Parkinson's, FTD), OncoGML (cancer prognosis), BioGML (blood sample validation), OtoGML and LAbyrInth (inner ear anomaly detection), plus DementIA for dementia differentiation. The company also offers custom software development and paid training workshops for healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • LAbyrInth detected inner ear anomalies at risk of developing hydrops that are invisible to radiologists with the naked eye, enabling earlier intervention before irreversible cochlear damage in Ménière's disease patients
+2 more records
Product overview1 text field

GeodAIsics offers a unified clinical decision support platform powered by proprietary Generative Manifold Learning (GML) AI technology. The core product portfolio includes BrainGML for brain MRI analysis, OncoGML for cancer prognosis, BioGML for biological sample validation, and OtoGML for inner ear imaging. All products share the same GML algorithmic foundation that creates patient digital twins for personalized medical analysis. The company also provides custom software development services using the same patented technology for specific customer applications in healthcare, laboratory, and medical device sectors.

Product and service8 records
1BrainGML
CategoryClinical Decision Support — Brain MRI
Description

Sophisticated MRI analysis software for detecting anatomical brain changes. Creates personalized atlases for neurodegenerative and psychiatric disorders including Alzheimer's, Parkinson's, and frontotemporal dementia. Includes DementIA functionality and BrainGML-AD variant.

2OncoGML
CategoryClinical Decision Support — Oncology
Description

Clinical decision support system predicting prognosis and treatment outcomes for cancer patients. Provides tailored treatment strategies based on patient profiles, with focus on elderly breast cancer patients.

3BioGML
CategoryClinical Decision Support — Biological Analysis
Description

Validates blood samples with personalized standards for enhanced disease detection. Develops atlases for kidney and liver disease identification. Used for quality control validation.

4OtoGML
CategoryClinical Decision Support — Inner Ear MRI
Description

Enables clinicians with tools for personalized inner ear MRI analysis. Detects structural abnormalities in inner ear including cochlea, vestibule, and semicircular canals. Aids diagnosis of Ménière's disease and labyrinthine anomalies.

5LAbyrInth
CategoryClinical Decision Support — Inner Ear Anomaly Detection
Description

Automatic detector of morphological anomalies in inner ear. Creates digital twins of cochlea (hearing) and vestibule/semicircular canals (balance). Award-winning innovation for diagnosing Ménière's disease and hydrops.

6DementIA
CategoryClinical Decision Support — Dementia
Description

AI software for dementia detection and differentiation. Part of BrainGML suite, on the path to CE marking. Distinguishes Alzheimer's from frontotemporal dementia, Lewy body disease, and vascular dementia.

7Custom Software Development
CategoryCustom AI Software Development Services
Description

Custom software development services using patented GML technology for specific customer applications. Targets middleware, LIS/HIS, pharmaceuticals, CROs, hospitals, laboratories, and medical device manufacturers.

8Professional Training Workshops
CategoryProfessional Training Services
Description

Paid in-person and remote training workshops for healthcare professionals on AI applications in neuroimaging and inner-ear imaging. Past sessions covered neuro-degenerative diseases, cochleo-vestibular disorders, and demyelinating diseases at €300 per session. Upcoming session (Sept 2025) on biological Alzheimer diagnosis at Institut Pasteur, priced at €50 for medical interns.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

GeodAIsics and HORIBA announced a partnership in September 2025 to develop an AI-powered sepsis detection solution. This represents a significant strategic alliance between GeodAIsics' generative AI technology and HORIBA's diagnostic systems capabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Les Biologistes Indépendants entered the capital of GeodAIsics as a strategic alliance to strengthen preventive medical biology reinforced by artificial intelligence. This investment represents both a financial and strategic partnership in the medical biology sector.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

BYG4lab signed a partnership agreement with GeodAIsics to strengthen Ynfectio, their epidemiology and infection control software, with an AI module. The collaboration enabled quick and efficient AI integration into BYG4lab's existing software, bringing respective expertise to achieve tangible results.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2022-11-01
Description

GeodAIsics partnered with Bayer for a November 2022 webinar targeting radiologists on the topic of 'Dementia and AI'. Bayer is a major pharmaceutical and life sciences company, and this partnership helped position GeodAIsics' DementIA software within the radiology community.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Institut Pasteur is GeodAIsics' academic partner for training and education. The September 2025 training session on biological Alzheimer diagnosis takes place at the Institut de l'Audition, part of Institut Pasteur. The partnership supports academic-level medical training combining neuroimaging and AI.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. AP-HP is France's largest hospital system and represents a key reference institution for clinical validation of GeodAIsics' technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. HCL is a major university hospital system in Lyon, France, involved in clinical validation of GeodAIsics' solutions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. CHU Grenoble is a key academic hospital partner for GeodAIsics, given the co-founders' ties to the Grenoble region.

9CHU Brest
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

geodaisics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. Centre Léon Bérard is a comprehensive cancer center in Lyon, relevant to OncoGML product validation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

14Université de Sydney (The University of Sydney)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. International academic partnership for research collaboration.

geodaisics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. Alexion is a pharmaceutical/biotechnology company (part of AstraZeneca), potentially a customer or research collaborator.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. Bracco is a pharmaceutical company specializing in diagnostic imaging, relevant to GeodAIsics' imaging-based AI solutions.

17MedicalPS
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. MedicalPS is a competitiveness cluster for medical technologies in the Grenoble area, supporting medtech innovation.

geodaisics.com
18Lyon Biopole
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. Lyon Biopole is a competitiveness cluster supporting companies in health industries and biotechnology in the Auvergne-Rhône-Alpes region.

geodaisics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page. Minalogic is a competitiveness cluster for digital technologies including AI and microelectronics in the Grenoble area.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

21Lille Climal
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on GeodAIsics' validations page.

geodaisics.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

French AI-for-health company using federated learning across hospitals for drug discovery, diagnostics, and clinical research. Comparable in French AI-health positioning and serving pharma/CRO customers like GeodAIsics' custom software business, though much larger and broader in scope.

TypeDirect peer
Description

French AI radiology company with CE-marked products for bone, chest, and mammography interpretation. Direct peer in geography (France), regulatory pathway (CE marking), and AI-driven radiology decision support for healthcare institutions.

TypeDirect peer
Description

French AI company developing MammoScreen 2.x for breast cancer screening using deep learning on mammograms. Comparable to GeodAIsics' OncoGML in applying AI to breast cancer imaging, with CE marking and European commercial focus.

TypeDirect peer
Description

Specializes in AI-based clinical decision support for neuroimaging, most notably for stroke detection and triage. Comparable to GeodAIsics' BrainGML in focusing on AI over brain imaging and care coordination for time-sensitive neurological conditions.

TypeDirect peer
Description

Cloud-native AI platform for medical imaging with FDA-cleared modules for cardiac and lung MRI/CT. Comparable to GeodAIsics as a clinical imaging AI platform with multiple specialty modules and a SaaS delivery model to healthcare institutions.

TypeBroad incumbent
Description

Major medical imaging and diagnostics vendor offering AI-Rad Companion for AI-augmented radiology and digital health platforms. Indirectly comparable as a broad incumbent that bundles AI radiology capabilities into its installed imaging base, putting competitive pressure on GeodAIsics' imaging AI modules.

TypeDirect peer
Description

AI medical imaging company with multiple CE-marked and FDA-cleared products for chest X-ray, head CT, and tuberculosis triage. Comparable to GeodAIsics' clinical decision support suite across multiple imaging modalities, though focused on Deep Learning.

TypeEmerging player
Description

AI clinical decision support for radiology covering 100+ findings on chest X-ray and CT. Comparable as a multi-module AI decision support suite aimed at radiologists, with overlapping scope to GeodAIsics' BrainGML and OtoGML in creating structured AI assistance for image interpretation.

TypeDirect peer
Description

French AI company focused on neuroimaging analysis, particularly for multiple sclerosis and other neurological conditions. Closely comparable to GeodAIsics' BrainGML on neuroimaging AI and is another French medtech using AI to support radiologists and neurologists.

TypeDirect peer
Description

AI-powered clinical decision support for medical imaging (CT, MRI, X-ray), with multiple FDA-cleared modules for radiology workflows. Directly comparable to GeodAIsics' AI-driven imaging decision support products, though Aidoc focuses on Deep Learning and emergency/acute care rather than manifold learning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GeodAIsics

Clinical Decision Support Softwaregeodaisics.com

GeodAIsics is a France-based DeepTech company that develops proprietary AI-powered clinical and biological decision-support software (BrainGML, OncoGML, BioGML, OtoGML, LAbyrInth) for hospitals, radiology centers, medical biology laboratories, medical-device manufacturers and CROs using its patented Generative Manifold Learning technology.

What GeodAIsics does

GeodAIsics SAS is a French DeepTech company founded in 2021 and headquartered in La Tronche (Grenoble), France, that develops clinical and biological decision-support software powered by its proprietary Generative Manifold Learning (GML) AI technology. GML is a generative AI methodology based on variety analysis that operates on low volumes of unlabeled routine-care data, builds personalized digital twins per patient, and detects anomalies (including disease subtypes) at population and individual level. The product portfolio comprises five proprietary software lines — BrainGML (brain MRI, including DementIA / BrainGML-AD for early Alzheimer's detection and differential dementia diagnosis), OncoGML (cancer prognosis and treatment outcome prediction, with focus on elderly breast cancer patients), BioGML (blood-sample validation with personalized reference values for kidney and liver disease), OtoGML (inner-ear MRI analysis including Ménière's disease), and LAbyrInth (automatic inner-ear anomaly detection) — all built on the same algorithmic foundation.

The company operates a dual go-to-market: (1) proprietary software licensed to hospitals, radiology centers, and biology laboratories, with BrainGML/DementIA on the path to CE marking as a medical device; and (2) custom AI software development using GML for medical-device manufacturers, LIS/HIS middleware vendors, pharmaceutical companies, CROs, and veterinary clinics, exemplified by the embedded AI module within BYG4lab's Ynfectio software. A secondary revenue stream is paid professional training workshops (historically €300 per session, €50 for interns) that double as a relationship-building channel with radiologists, neurologists and ORL specialists. Distribution is primarily direct-sales driven in France with extensions into validation partnerships across French university hospitals (AP-HP, HCL, CHU Grenoble, CHU Brest, CHU Rouen, CHU Nice, Centre Léon Bérard) and one international academic link (University of Sydney), supplemented by congress presence (JFR 2022, SFNR 2023), Bayer-co-branded webinars, and strategic partnerships with HORIBA (sepsis detection, 2025) and Les Biologistes Indépendants (capital entry 2025).

GeodAIsics is privately held, has approximately 14 team members, and has raised €400,000 from 10 physician business angels in February 2023 as the only disclosed equity financing to date. The founding team combines three medical doctors (neuroradiology, oncogenetics, medical biology) with a PhD in AI as CSO, and the company holds two pending patents covering its core GML methodologies.

GeodAIsics firmographics

Firmographics
Name
GeodAIsics
Legal name
Geodaisics
Website
https://geodaisics.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
GeodAIsics is a France-based DeepTech company that develops proprietary AI-powered clinical and biological decision-support software (BrainGML, OncoGML, BioGML, OtoGML, LAbyrInth) for hospitals, radiology centers, medical biology laboratories, medical-device manufacturers and CROs using its patented Generative Manifold Learning technology.
Ownership category
akta.pro rank

GeodAIsics industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Keywords

  • Clinical decision support
  • Medical imaging AI
  • Generative manifold learning
  • Digital twin healthcare
  • Radiology software

Where GeodAIsics is headquartered

Location

Headquarters

HQ city
Grenoble
HQ country
France
HQ region
Europe

Offices1 record

Markets served

GeodAIsics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Proprietary Software Licenses: GeodAIsics develops and licenses proprietary clinical decision support software products (BrainGML, OncoGML, BioGML, OtoGML) to healthcare institutions, hospitals, and medical professionals. These are sold as software licenses, likely on a subscription or one-time license basis, targeting CE marking for regulatory approval.
  2. Custom Software Development: GeodAIsics develops custom software solutions for specific client applications using the same patented GML technology. Target clients include biological testing system manufacturers, quality control manufacturers, middleware providers, LIS/HIS vendors, pharmaceutical companies, CROs, hospitals, veterinary clinics, and medical device manufacturers.
  3. Professional Training and Workshops: GeodAIsics offers paid professional training workshops for healthcare professionals (radiologists, neurologists, geriatricians) on AI applications in medical imaging. Training is offered at €300 per session (past workshops) and €50 for interns (upcoming), conducted in-person and remotely.

Pricing tiers

ModelBillingPrice
Unit PricingOne time/ perpetual licenseProfessional Training - Past Sessions
Unit PricingOne time/ perpetual licenseUpcoming Training (September 2025)
SubscriptionAnnualBrainGML-AD Software License

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

GeodAIsics product offering

Product offering

Core offering

GeodAIsics develops and licenses proprietary clinical decision support software for medical imaging and biological analysis, powered by its patented Generative Manifold Learning (GML) AI technology. Core products include BrainGML (brain MRI analysis for Alzheimer's, Parkinson's, FTD), OncoGML (cancer prognosis), BioGML (blood sample validation), OtoGML and LAbyrInth (inner ear anomaly detection), plus DementIA for dementia differentiation. The company also offers custom software development and paid training workshops for healthcare professionals.

Product overview

GeodAIsics offers a unified clinical decision support platform powered by proprietary Generative Manifold Learning (GML) AI technology. The core product portfolio includes BrainGML for brain MRI analysis, OncoGML for cancer prognosis, BioGML for biological sample validation, and OtoGML for inner ear imaging. All products share the same GML algorithmic foundation that creates patient digital twins for personalized medical analysis. The company also provides custom software development services using the same patented technology for specific customer applications in healthcare, laboratory, and medical device sectors.

Differentiator

Problem solved

Functional benefit

Brands

  • BrainGML: MRI analysis software for detecting anatomical changes in the brain, particularly for neurodegenerative and psychiatric disorders such as Alzheimer's, Parkinson's, and FTD.
  • BrainGML-AD
  • OncoGML
  • BioGML
  • OtoGML
  • LAbyrInth
  • DementIA

Products and services

  • BrainGML Sophisticated MRI analysis software for detecting anatomical brain changes. Creates personalized atlases for neurodegenerative and psychiatric disorders including Alzheimer's, Parkinson's, and frontotemporal dementia. Includes DementIA functionality and BrainGML-AD variant.
  • OncoGML Clinical decision support system predicting prognosis and treatment outcomes for cancer patients. Provides tailored treatment strategies based on patient profiles, with focus on elderly breast cancer patients.
  • BioGML Validates blood samples with personalized standards for enhanced disease detection. Develops atlases for kidney and liver disease identification. Used for quality control validation.
  • OtoGML Enables clinicians with tools for personalized inner ear MRI analysis. Detects structural abnormalities in inner ear including cochlea, vestibule, and semicircular canals. Aids diagnosis of Ménière's disease and labyrinthine anomalies.
  • LAbyrInth Automatic detector of morphological anomalies in inner ear. Creates digital twins of cochlea (hearing) and vestibule/semicircular canals (balance). Award-winning innovation for diagnosing Ménière's disease and hydrops.
  • DementIA AI software for dementia detection and differentiation. Part of BrainGML suite, on the path to CE marking. Distinguishes Alzheimer's from frontotemporal dementia, Lewy body disease, and vascular dementia.
  • Custom Software Development Custom software development services using patented GML technology for specific customer applications. Targets middleware, LIS/HIS, pharmaceuticals, CROs, hospitals, laboratories, and medical device manufacturers.
  • Professional Training Workshops Paid in-person and remote training workshops for healthcare professionals on AI applications in neuroimaging and inner-ear imaging. Past sessions covered neuro-degenerative diseases, cochleo-vestibular disorders, and demyelinating diseases at €300 per session. Upcoming session (Sept 2025) on biological Alzheimer diagnosis at Institut Pasteur, priced at €50 for medical interns.

Quantifiable outcome

  • LAbyrInth detected inner ear anomalies at risk of developing hydrops that are invisible to radiologists with the naked eye, enabling earlier intervention before irreversible cochlear damage in Ménière's disease patients
  • +2 more outcomes

Companies that use GeodAIsics

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

GeodAIsics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature10 records

GeodAIsics partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered core and minor.

  • HORIBAcoreStrategic or Co-development Partner · 1 September 2025GeodAIsics and HORIBA announced a partnership in September 2025 to develop an AI-powered sepsis detection solution. This represents a significant strategic alliance between GeodAIsics' generative AI technology and HORIBA's diagnostic systems capabilities.
  • Les Biologistes Indépendants (LBI)coreStrategic or Co-development Partner · 1 September 2025Les Biologistes Indépendants entered the capital of GeodAIsics as a strategic alliance to strengthen preventive medical biology reinforced by artificial intelligence. This investment represents both a financial and strategic partnership in the medical biology sector.
  • BYG4labcoreStrategic or Co-development Partner · 1 January 2024BYG4lab signed a partnership agreement with GeodAIsics to strengthen Ynfectio, their epidemiology and infection control software, with an AI module. The collaboration enabled quick and efficient AI integration into BYG4lab's existing software, bringing respective expertise to achieve tangible results.
  • BayercoreGTM or Marketing Partner · 1 November 2022GeodAIsics partnered with Bayer for a November 2022 webinar targeting radiologists on the topic of 'Dementia and AI'. Bayer is a major pharmaceutical and life sciences company, and this partnership helped position GeodAIsics' DementIA software within the radiology community.
  • Institut PasteurcoreStrategic or Co-development PartnerInstitut Pasteur is GeodAIsics' academic partner for training and education. The September 2025 training session on biological Alzheimer diagnosis takes place at the Institut de l'Audition, part of Institut Pasteur. The partnership supports academic-level medical training combining neuroimaging and AI.
  • AP-HP (Assistance Publique - Hôpitaux de Paris)minorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. AP-HP is France's largest hospital system and represents a key reference institution for clinical validation of GeodAIsics' technology.
  • HCL (Hospices Civils de Lyon)minorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. HCL is a major university hospital system in Lyon, France, involved in clinical validation of GeodAIsics' solutions.
  • CHU Grenoble AlpesminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. CHU Grenoble is a key academic hospital partner for GeodAIsics, given the co-founders' ties to the Grenoble region.
  • CHU BrestminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.
  • CHU RouenminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.
  • CHU NiceminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.
  • Centre Léon BérardminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. Centre Léon Bérard is a comprehensive cancer center in Lyon, relevant to OncoGML product validation.
  • Fondation RothschildminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.
  • Université de Sydney (The University of Sydney)minorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. International academic partnership for research collaboration.
  • AlexionminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. Alexion is a pharmaceutical/biotechnology company (part of AstraZeneca), potentially a customer or research collaborator.
  • BraccominorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. Bracco is a pharmaceutical company specializing in diagnostic imaging, relevant to GeodAIsics' imaging-based AI solutions.
  • MedicalPSminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. MedicalPS is a competitiveness cluster for medical technologies in the Grenoble area, supporting medtech innovation.
  • Lyon BiopoleminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. Lyon Biopole is a competitiveness cluster supporting companies in health industries and biotechnology in the Auvergne-Rhône-Alpes region.
  • MinalogicminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page. Minalogic is a competitiveness cluster for digital technologies including AI and microelectronics in the Grenoble area.
  • BioAmiensminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.
  • Lille ClimalminorStrategic or Co-development PartnerListed as a partner on GeodAIsics' validations page.

Scale indicators3 records

Recent moves6 records

Expansion highlights7 records

GeodAIsics competitors and assessment

Company assessment

Broad incumbents

  • Owkin: French AI-for-health company using federated learning across hospitals for drug discovery, diagnostics, and clinical research. Comparable in French AI-health positioning and serving pharma/CRO customers like GeodAIsics' custom software business, though much larger and broader in scope.
  • Siemens Healthineers (AI-Rad Companion): Major medical imaging and diagnostics vendor offering AI-Rad Companion for AI-augmented radiology and digital health platforms. Indirectly comparable as a broad incumbent that bundles AI radiology capabilities into its installed imaging base, putting competitive pressure on GeodAIsics' imaging AI modules.

Direct peers

  • Gleamer: French AI radiology company with CE-marked products for bone, chest, and mammography interpretation. Direct peer in geography (France), regulatory pathway (CE marking), and AI-driven radiology decision support for healthcare institutions.
  • Therapixel: French AI company developing MammoScreen 2.x for breast cancer screening using deep learning on mammograms. Comparable to GeodAIsics' OncoGML in applying AI to breast cancer imaging, with CE marking and European commercial focus.
  • Viz.ai: Specializes in AI-based clinical decision support for neuroimaging, most notably for stroke detection and triage. Comparable to GeodAIsics' BrainGML in focusing on AI over brain imaging and care coordination for time-sensitive neurological conditions.
  • Arterys: Cloud-native AI platform for medical imaging with FDA-cleared modules for cardiac and lung MRI/CT. Comparable to GeodAIsics as a clinical imaging AI platform with multiple specialty modules and a SaaS delivery model to healthcare institutions.
  • Qure.ai: AI medical imaging company with multiple CE-marked and FDA-cleared products for chest X-ray, head CT, and tuberculosis triage. Comparable to GeodAIsics' clinical decision support suite across multiple imaging modalities, though focused on Deep Learning.
  • Pixyl: French AI company focused on neuroimaging analysis, particularly for multiple sclerosis and other neurological conditions. Closely comparable to GeodAIsics' BrainGML on neuroimaging AI and is another French medtech using AI to support radiologists and neurologists.
  • Aidoc: AI-powered clinical decision support for medical imaging (CT, MRI, X-ray), with multiple FDA-cleared modules for radiology workflows. Directly comparable to GeodAIsics' AI-driven imaging decision support products, though Aidoc focuses on Deep Learning and emergency/acute care rather than manifold learning.

Emerging players

  • Annalise.ai: AI clinical decision support for radiology covering 100+ findings on chest X-ray and CT. Comparable as a multi-module AI decision support suite aimed at radiologists, with overlapping scope to GeodAIsics' BrainGML and OtoGML in creating structured AI assistance for image interpretation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

GeodAIsics social profiles

Digital presence

GeodAIsics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GeodAIsics leadership team

Management profile

Number of profiles

Profiles15 records

GeodAIsics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GeodAIsics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GeodAIsics

What does GeodAIsics do?

GeodAIsics develops and licenses proprietary clinical decision support software for medical imaging and biological analysis, powered by its patented Generative Manifold Learning (GML) AI technology. Core products include BrainGML (brain MRI analysis for Alzheimer's, Parkinson's, FTD), OncoGML (cancer prognosis), BioGML (blood sample validation), OtoGML and LAbyrInth (inner ear anomaly detection), plus DementIA for dementia differentiation. The company also offers custom software development and paid training workshops for healthcare professionals.

Is GeodAIsics a public or private company?

GeodAIsics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was GeodAIsics founded?

GeodAIsics was founded in 2021. It employs 11 to 50 people.

Where is GeodAIsics based?

GeodAIsics is headquartered in Grenoble, France, in the Europe region.

How does GeodAIsics make money?

Three revenue lines are on record. Proprietary Software Licenses are the primary driver. The others are custom Software Development and professional Training and Workshops.

Who are GeodAIsics's main competitors?

Broad incumbents on record are Owkin and Siemens Healthineers (AI-Rad Companion). Direct peers are Gleamer, Therapixel, Viz.ai, Arterys, Qure.ai, Pixyl and Aidoc. Annalise.ai is listed as an emerging player.

Does GeodAIsics have an API?

No public API is recorded for GeodAIsics.

What industry is GeodAIsics in?

GeodAIsics's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 5417 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales